Microspheres for controlled release drug delivery

Controlled release drug delivery employs drug-encapsulating devices from which therapeutic agents may be released at controlled rates for long periods of time, ranging from days to months. Such systems offer numerous advantages over traditional methods of drug delivery, including tailoring of drug release rates, protection of fragile drugs and increased patient comfort and compliance. Polymeric microspheres are ideal vehicles for many controlled delivery applications due to their ability to encapsulate a variety of drugs, biocompatibility, high bioavailability and sustained drug release characteristics. Research discussed in this review is focused on improving large-scale manufacturing, maintaining drug stability and enhancing control of drug release rates. This paper describes methods of microparticle fabrication and the major factors controlling the release rates of encapsulated drugs. Furthermore, recent advances in the use of polymer microsphere-based systems for delivery of single-shot vaccines, plasmid DNA and therapeutic proteins are discussed, as well as some future directions of microsphere research.

[1]  George Poste,et al.  Site–Specific (Targeted) Drug Delivery in Cancer Therapy , 1983, Bio/Technology.

[2]  R. Langer,et al.  Polyanhydride microsphere formulation by solvent extraction. , 1988, Journal of pharmaceutical sciences.

[3]  R. Arshady,et al.  Preparation of microspheres and microcapsules by interfacial polycondensation techniques. , 1989, Journal of microencapsulation.

[4]  J. Benoit,et al.  In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method. , 1989, Biomaterials.

[5]  P. Felgner,et al.  Cationic liposome mediated transfection. , 1989, Proceedings of the Western Pharmacology Society.

[6]  P. Felgner,et al.  Cationic liposome-mediated transfection , 1989, Nature.

[7]  T Niwa,et al.  Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method. , 1990, Journal of pharmaceutical sciences.

[8]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[9]  H. Ploehn,et al.  Interactions between colloidal particles and soluble polymers , 1990 .

[10]  Y. Ikada,et al.  Phagocytosis of polymer microspheres by macrophages , 1990 .

[11]  I. Yamakawa,et al.  In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method. , 1992, Journal of pharmaceutical sciences.

[12]  S. Fukushima,et al.  Control of drug release with a combination of prodrug and polymer matrix: antitumor activity and release profiles of 2',3'-diacyl-5-fluoro-2'-deoxyuridine from poly(3-hydroxybutyrate) microspheres. , 1992, Journal of pharmaceutical sciences.

[13]  R. Arshady,et al.  Suspension, emulsion, and dispersion polymerization: A methodological survey , 1992 .

[14]  R Langer,et al.  Erosion kinetics of hydrolytically degradable polymers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Yoshiki Sano,et al.  Micron‐sized polymeric microsphere by suspension polymerization , 1993 .

[16]  P. Giunchedi,et al.  Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation. , 1993, Journal of microencapsulation.

[17]  Robert Langer,et al.  Modeling of Polymer Erosion , 1993 .

[18]  R. Singh,et al.  Preparation, characterization and in vitro release kinetics of aminophylline loaded albumin microspheres , 1994 .

[19]  P. Corre,et al.  Preparation and characterization of bupivacaine-loaded polylactide and polylactide-co-glycolide microspheres , 1994 .

[20]  R. Gupta,et al.  Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. , 1994, Vaccine.

[21]  R. Langer,et al.  Preparation and evaluation of polyanhydride microspheres containing gonadotropin-releasing hormone (GnRH), for inducing ovulation and spermiation in fish , 1995 .

[22]  A. Berns,et al.  Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Ganesh,et al.  Comparison of Solubilization of Hydrocarbons in (PEO-PPO) Diblock versus (PEO-PPO-PEO) Triblock Copolymer Micelles , 1996, Journal of colloid and interface science.

[24]  S. Knechtle,et al.  Naked DNA delivered intraportally expresses efficiently in hepatocytes. , 1996, Gene therapy.

[25]  K. Leong,et al.  DNA-Chitosan nanospheres for gene delivery , 1996 .

[26]  R. Vile,et al.  Retroviral vectors. From laboratory tools to molecular medicine. , 1996, Molecular biotechnology.

[27]  X M Li,et al.  Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. , 1996, Vaccine.

[28]  R K Gupta,et al.  Pulsed controlled-released system for potential use in vaccine delivery. , 1996, Journal of pharmaceutical sciences.

[29]  S. Goldstein,et al.  Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Fredro-Kumbaradzi,et al.  Preparation, Physical Characterization, Mechanisms of Drug/Polymer Interactions, and Stability Studies of Controlled-Release Solid Dispersion Granules Containing Weak Base as Active Substance , 1996 .

[31]  R. Mehta,et al.  Peptide containing microspheres from low molecular weight and hydrophilic poly(d,l-lactide-co-glycolide) , 1996 .

[32]  R. Gupta,et al.  Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen. , 1996, Journal of pharmaceutical sciences.

[33]  R. Vile,et al.  Retroviral vectors , 1996 .

[34]  R. Webster,et al.  DNA vaccines. , 1996, AIDS research and human retroviruses.

[35]  K. C. Ting,et al.  Microparticles of poly(dl-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery , 1997 .

[36]  Dorian A. Canelas,et al.  Polymerizations in Liquid and Supercritical Carbon Dioxide , 1997 .

[37]  O'donnell,et al.  Preparation of microspheres by the solvent evaporation technique. , 1997, Advanced drug delivery reviews.

[38]  Donald E. Chickering,et al.  Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.

[39]  J. Park,et al.  Double-walled microparticles for single shot vaccine , 1997 .

[40]  Y. Uemura,et al.  Preparation of monodispersed polymeric microspheres for toner particles by the shirasu Porous Glass membrane emulsification technique , 1997 .

[41]  R. Mumper,et al.  Plasmid delivery to muscle: Recent advances in polymer delivery systems. , 1998, Advanced drug delivery reviews.

[42]  M. Hedley,et al.  Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses , 1998, Nature Medicine.

[43]  J L Cleland,et al.  Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing response. , 1998, Journal of pharmaceutical sciences.

[44]  Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines. , 1998, Biomaterials.

[45]  M. Alonso,et al.  Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[46]  T. Kissel,et al.  Synthesis of bioadhesive poly(acrylic acid) nano- and microparticles using an inverse emulsion polymerization method for the entrapment of hydrophilic drug candidates. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[47]  J. Cleland Solvent Evaporation Processes for the Production of Controlled Release Biodegradable Microsphere Formulations for Therapeutics and Vaccines , 1998, Biotechnology progress.

[48]  S. Goldstein,et al.  Gene therapy for tissue repair and regeneration. , 1998, Advanced drug delivery reviews.

[49]  D. Quenelle,et al.  Use of Microsphere Technology for Targeted Delivery of Rifampin to Mycobacterium tuberculosis-Infected Macrophages , 1998, Antimicrobial Agents and Chemotherapy.

[50]  M Morlock,et al.  Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[51]  L. Simonsen,et al.  Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. , 1999, Bulletin of the World Health Organization.

[52]  G. Kwon,et al.  Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[53]  D. Hammer,et al.  Polymersomes: tough vesicles made from diblock copolymers. , 1999, Science.

[54]  David J. Mooney,et al.  DNA delivery from polymer matrices for tissue engineering , 1999, Nature Biotechnology.

[55]  M. Radwan,et al.  In vivo performance of parenteral theophylline-loaded polyisobutylcyanoacrylate nanoparticles in rats. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[56]  J. Cleland Single-administration vaccines: controlled-release technology to mimic repeated immunizations. , 1999, Trends in biotechnology.

[57]  T. Park,et al.  Stereocomplex formation between enantiomeric PLA–PEG–PLA triblock copolymers: Characterization and use as protein‐delivery microparticulate carriers , 1999 .

[58]  A. Coombes,et al.  Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines. , 1999, Vaccine.

[59]  M. Nagai,et al.  Preparation of uniform poly(lactide) microspheres by employing the Shirasu Porous Glass (SPG) emulsification technique , 1999 .

[60]  C. Sharma,et al.  Alginate Encapsulated Bioadhesive Chitosan Microspheres for Intestinal Drug Delivery , 1999, Journal of biomaterials applications.

[61]  A. Klibanov,et al.  FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[62]  Y. Capan,et al.  Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[63]  P. G. Shao,et al.  Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres. , 1999, Pharmaceutical development and technology.

[64]  C. Harding,et al.  Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes. , 1999, Journal of immunology.

[65]  H. Sah Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres. , 1999, PDA journal of pharmaceutical science and technology.

[66]  D. Putnam,et al.  PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. , 1999, Journal of pharmaceutical sciences.

[67]  A. Zimmer,et al.  Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers. , 1999, Methods.

[68]  T. Kissel,et al.  Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[69]  P. Artursson,et al.  Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[70]  H. Merkle,et al.  Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[71]  C. Patrick,et al.  Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. , 2000, Journal of biomedical materials research.

[72]  R. Proulx,et al.  A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle , 2000, Gene Therapy.

[73]  L. Lunsford,et al.  Tissue Distribution and Persistence in Mice of Plasmid DNA Encapsulated in a PLGA-Based Microsphere Delivery Vehicle , 2000, Journal of drug targeting.

[74]  R. Levy,et al.  Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles , 2000, Gene Therapy.

[75]  P. Sinko,et al.  Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres. I. In vitro characterization. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[76]  R. A. Jain,et al.  Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[77]  K. S. Chen,et al.  In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters. , 2000, Journal of microencapsulation.

[78]  P. Sinko,et al.  Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres. II. In vivo investigation. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[79]  Yanhua Zhang,et al.  In vitro degradation and release profiles of poly-DL-lactide-poly(ethylene glycol) microspheres with entrapped proteins , 2000 .

[80]  A. Simon,et al.  Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. , 2000, Science.

[81]  M. Benoit,et al.  Parameters influencing the antigen release from spray-dried poly(DL-lactide) microparticles. , 2000, International journal of pharmaceutics.

[82]  G. Farrar,et al.  Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[83]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[84]  C. Sturesson,et al.  Incorporation of protein in PLG-microspheres with retention of bioactivity. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[85]  N R Lemoine,et al.  Cancer gene therapy: hard lessons and new courses , 2000, Gene Therapy.

[86]  A. Mikos,et al.  Controlled release of transforming growth factor β1 from biodegradable polymer microparticles , 2000 .

[87]  X. Li,et al.  Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethylene glycol) microspheres. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[88]  A. Kabanov,et al.  Block and Graft Copolymers and Nanogel™ Copolymer Networks for DNA Delivery into Cell , 2000, Journal of drug targeting.

[89]  K. Fujioka,et al.  Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid. , 2001, Vaccine.

[90]  S. Schwendeman,et al.  Stabilization of a model formalinized protein antigen encapsulated in poly(lactide-co-glycolide)-based microspheres. , 2001, Journal of pharmaceutical sciences.

[91]  P. R. Chatterji,et al.  PREPARATION OF LINEAR AND CROSSLINKED POLYMER MICROSPHERES BY DISPERSION POLYMERIZATION , 2001 .

[92]  J L Cleland,et al.  Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[93]  D W Pack,et al.  Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[94]  R. Mulligan,et al.  Plasmid DNA encapsulation and release from solvent diffusion nanospheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[95]  Yi Yan Yang,et al.  Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. , 2001, Biomaterials.

[96]  J L Cleland,et al.  Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. , 2001, Journal of pharmaceutical sciences.

[97]  H. Merkle,et al.  Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[98]  Y. Byun,et al.  Long-term delivery of all-trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres. , 2001, International journal of pharmaceutics.

[99]  J. Ulmer,et al.  Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines , 2001, Journal of Virology.

[100]  F. Bigucci,et al.  Self-assembling poly(vinyl alcohol) derivatives, interactions with drugs and control of release. , 2001, Journal of pharmaceutical sciences.

[101]  R. Liggins,et al.  Paclitaxel loaded poly(L-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers. , 2001, International journal of pharmaceutics.

[102]  T. Park,et al.  Pegylation enhances protein stability during encapsulation in PLGA microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[103]  Shaobing Zhou,et al.  In vitro degradation characteristics of poly-DL-lactide-poly(ethylene glycol) microspheres containing human serum albumin , 2002 .

[104]  A. Göpferich,et al.  Why degradable polymers undergo surface erosion or bulk erosion. , 2002, Biomaterials.

[105]  Kristi S. Anseth,et al.  Compressed Antisolvent Precipitation and Photopolymerization To Form Highly Cross-Linked Polymer Particles , 2002 .

[106]  A. Coombes,et al.  Enhanced immunogenicity of a hepatitis B virus peptide vaccine using oligosaccharide ester derivative microparticles. , 2002, Vaccine.

[107]  Lichun Lu,et al.  Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles. , 2002, Biomaterials.

[108]  T. Anchordoquy,et al.  Shear-induced degradation of plasmid DNA. , 2002, Journal of pharmaceutical sciences.

[109]  Dennis E. Discher,et al.  Polymer Vesicles , 2022 .

[110]  Balaji Narasimhan,et al.  Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. , 2002, Biomaterials.

[111]  Steven P Schwendeman,et al.  Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. , 2002, Critical reviews in therapeutic drug carrier systems.

[112]  Dennis E. Discher,et al.  Polymer vesicles : Materials science: Soft surfaces , 2002 .

[113]  M. Ercan,et al.  Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[114]  Cory Berkland,et al.  Precise control of PLG microsphere size provides enhanced control of drug release rate. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[115]  Abraham J Domb,et al.  Polyanhydrides: an overview. , 2002, Advanced drug delivery reviews.

[116]  K. Griebenow,et al.  Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention , 2002 .

[117]  S. Lofthouse Immunological aspects of controlled antigen delivery. , 2002, Advanced drug delivery reviews.

[118]  D. Volkin,et al.  Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. , 2002, Journal of pharmaceutical sciences.

[119]  B. Narasimhan,et al.  Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[120]  Lonnie D Shea,et al.  Drug-releasing scaffolds fabricated from drug-loaded microspheres. , 2002, Journal of biomedical materials research.

[121]  Shaobing Zhou,et al.  Investigation on preparation and protein release of biodegradable polymer microspheres as drug‐delivery system , 2002 .

[122]  Mushir M. Ali,et al.  Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants. , 2002, International journal of pharmaceutics.

[123]  Alexander V Kabanov,et al.  Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. , 2002, Advanced drug delivery reviews.

[124]  S. Schwendeman,et al.  Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D,L-lactide-co-glycolide) implants. , 2002, Biomaterials.

[125]  Yu Liu,et al.  Influences of preparation conditions on particle size and DNA-loading efficiency for poly(DL-lactic acid-polyethylene glycol) microspheres entrapping free DNA. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[126]  K. Griebenow,et al.  Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[127]  Cheng Luo,et al.  Putative hAPN receptor binding sites in SARS_CoV spike protein. , 2003, Acta pharmacologica Sinica.

[128]  D. Maysinger,et al.  Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles , 2003, Science.

[129]  M. Wirth,et al.  Stabilisation and determination of the biological activity of L-asparaginase in poly(D,L-lactide-co-glycolide) nanospheres. , 2003, International journal of pharmaceutics.

[130]  K. Griebenow,et al.  Stabilization of alpha-chymotrypsin at the CH2Cl2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[131]  L. Bromberg,et al.  Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell layers. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[132]  K. Griebenow,et al.  Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres. , 2003, Biotechnology and bioengineering.

[133]  N. Medlicott,et al.  A prolonged immune response to antigen delivered in poly (∊‐caprolactone) microparticles , 2003 .

[134]  Kazunori Kataoka,et al.  PEGylated nanoparticles for biological and pharmaceutical applications. , 2003, Advanced drug delivery reviews.

[135]  T. Ross,et al.  Particle-based vaccines for HIV-1 infection. , 2003, Current drug targets. Infectious disorders.

[136]  F. Zoulim,et al.  Progress in DNA vaccine for prophylaxis and therapy of hepatitis B. , 2003, Vaccine.

[137]  J. Talmadge,et al.  Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity. , 2003, Vaccine.

[138]  N. Medlicott,et al.  A prolonged immune response to antigen delivered in poly (epsilon-caprolactone) microparticles. , 2003, Immunology and cell biology.

[139]  S. Mudzinski,et al.  A two-component modular approach for enhancing T-cell activation utilizing a unique anti-FcgammaRI-streptavidin construct and microspheres coated with biotinylated-antigen. , 2003, Biomolecular engineering.

[140]  M. Alonso,et al.  Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines , 1997, Pharmaceutical Research.

[141]  Robert Langer,et al.  Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres , 1991, Pharmaceutical Research.

[142]  C. Berkland,et al.  PLG Microsphere Size Controls Drug Release Rate Through Several Competing Factors , 2003, Pharmaceutical Research.

[143]  B. Amsden,et al.  The Production of Uniformly Sized Polymer Microspheres , 1999, Pharmaceutical Research.

[144]  T. Burke,et al.  The Acidic Microclimate in Poly(lactide-co-glycolide) Microspheres Stabilizes Camptothecins , 1999, Pharmaceutical Research.

[145]  Robert Langer,et al.  Polyanhydride Mierospheres that Display Near-Constant Release of Water-Soluble Model Drug Compounds , 1993, Pharmaceutical Research.

[146]  Y. Capan,et al.  Preparation and Characterization of Poly (D,L-Lactide-Co-Glycolide) Microspheres for Controlled Release of Poly(L-Lysine) Complexed Plasmid DNA , 1999, Pharmaceutical Research.

[147]  M. Goosen,et al.  A Parallel plate electrostatic droplet generator: Parameters affecting microbead size , 1994, Applied Microbiology and Biotechnology.

[148]  R. Reszka,et al.  Pharmaceutical Evaluation of Gas-Filled Microparticles as Gene Delivery System , 2004, Pharmaceutical Research.

[149]  Robert Langer,et al.  Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres , 2004, Pharmaceutical Research.

[150]  Wenlei Jiang,et al.  Stabilization and Controlled Release of Bovine Serum Albumin Encapsulated in Poly(D, L-lactide) and Poly(ethylene glycol) Microsphere Blends , 2001, Pharmaceutical Research.

[151]  K. Griebenow,et al.  Co-lyophilization of bovine serum albumin (BSA) with poly(ethylene glycol) improves efficiency of BSA encapsulation and stability in polyester microspheres by a solid-in-oil-in-oil technique , 2002, Biotechnology Letters.

[152]  W. Mark Saltzman,et al.  Controlled DNA Delivery Systems , 1999, Pharmaceutical Research.